Related Experiment Video
Updated: Aug 11, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Perceived Competence and GLP-1RA Weight Management Engagement: Mixed-Methods Insights From Six Patient Groups
Jane A McElroy1, Isabella Bertarelli2, Chloe Maltagliati1
1Department of Family and Community Medicine, University of Missouri, Columbia, Missouri, USA.
Obesity (Silver Spring, Md.)
|August 10, 2026
Summary
Patients
Area of Science:
- Endocrinology
- Behavioral Science
- Pharmacology
Background:
- Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly used for weight management.
- Understanding patient experiences is crucial for optimizing treatment outcomes.
- Perspectives vary across different stages of GLP-1RA therapy.
Purpose of the Study:
- To explore patient perspectives on GLP-1RAs for weight loss.
- To analyze experiences from initial consideration to discontinuation.
- To identify factors influencing patient engagement and goal achievement.
Main Methods:
- A mixed-methods approach using surveys and semi-structured interviews.
- Participants categorized into six groups based on therapy status and goal achievement.
- Qualitative and quantitative analyses to identify key themes and differences.
Main Results:
- Heterogeneity in psychosocial and behavioral profiles observed among participants.
- Higher perceived competence, intrinsic motivation, and self-monitoring in groups with goal achievement.
- Perceived competence significantly differed between groups, particularly in early-stage vs. successful long-term users.
Conclusions:
- Patient experiences with GLP-1RAs for weight loss are diverse.
- Perceived competence is a key differentiator in patient engagement.
- Tailored behavioral support is essential for successful weight loss journeys with GLP-1RAs.
Related Concept Videos
Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Assessment of the Gastrointestinal System II: Health Perception Pattern
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include: